BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 34560720)

  • 1. Trends in Diagnosis and Treatment of Metastatic Cancer in the United States.
    Lehrer EJ; Stoltzfus KC; Jones BM; Gusani NJ; Walter V; Wang M; Trifiletti DM; Siva S; Louie AV; Zaorsky NG
    Am J Clin Oncol; 2021 Nov; 44(11):572-579. PubMed ID: 34560720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Annual Report to the Nation on the Status of Cancer, part I: National cancer statistics.
    Cronin KA; Lake AJ; Scott S; Sherman RL; Noone AM; Howlader N; Henley SJ; Anderson RN; Firth AU; Ma J; Kohler BA; Jemal A
    Cancer; 2018 Jul; 124(13):2785-2800. PubMed ID: 29786848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Future trends in incidence and long-term survival of metastatic cancer in the United States.
    Hudock NL; Mani K; Khunsriraksakul C; Walter V; Nekhlyudov L; Wang M; Lehrer EJ; Hudock MR; Liu DJ; Spratt DE; Zaorsky NG
    Commun Med (Lond); 2023 May; 3(1):76. PubMed ID: 37244961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in Cancer Incidence in US Adolescents and Young Adults, 1973-2015.
    Scott AR; Stoltzfus KC; Tchelebi LT; Trifiletti DM; Lehrer EJ; Rao P; Bleyer A; Zaorsky NG
    JAMA Netw Open; 2020 Dec; 3(12):e2027738. PubMed ID: 33258907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Italian cancer figures, report 2012: Cancer in children and adolescents.
    ; ;
    Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Past, Current, and Future Incidence Rates and Burden of Metastatic Prostate Cancer in the United States.
    Kelly SP; Anderson WF; Rosenberg PS; Cook MB
    Eur Urol Focus; 2018 Jan; 4(1):121-127. PubMed ID: 29162421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
    ; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
    Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contemporary Trends in the Incidence of Metastatic Prostate Cancer Among US Men: Results from Nationwide Analyses.
    Dalela D; Sun M; Diaz M; Karabon P; Seisen T; Trinh QD; Menon M; Abdollah F
    Eur Urol Focus; 2019 Jan; 5(1):77-80. PubMed ID: 28753893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Annual report to the nation on the status of cancer, part 1: National cancer statistics.
    Cronin KA; Scott S; Firth AU; Sung H; Henley SJ; Sherman RL; Siegel RL; Anderson RN; Kohler BA; Benard VB; Negoita S; Wiggins C; Cance WG; Jemal A
    Cancer; 2022 Dec; 128(24):4251-4284. PubMed ID: 36301149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in central nervous system tumor incidence relative to other common cancers in adults, adolescents, and children in the United States, 2000 to 2010.
    Gittleman HR; Ostrom QT; Rouse CD; Dowling JA; de Blank PM; Kruchko CA; Elder JB; Rosenfeld SS; Selman WR; Sloan AE; Barnholtz-Sloan JS
    Cancer; 2015 Jan; 121(1):102-12. PubMed ID: 25155924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in Primary Surgical Resection and Chemotherapy for Metastatic Colorectal Cancer, 2000-2016.
    Sanford NN; Folkert MR; Aguilera TA; Beg MS; Kazmi SA; Sanjeevaiah A; Zeh HJ; Farkas L
    Am J Clin Oncol; 2020 Dec; 43(12):850-856. PubMed ID: 32976176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in the Incidence of Early-Onset Colorectal Adenocarcinoma Among Black and White US Residents Aged 40 to 49 Years, 2000-2017.
    Montminy EM; Zhou M; Maniscalco L; Penrose H; Yen T; Patel SG; Wu XC; Karlitz JJ
    JAMA Netw Open; 2021 Nov; 4(11):e2130433. PubMed ID: 34751760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 20-Year Comparative Survival and Mortality of Cancer of the Stomach by Age, Sex, Race, Stage, Grade, Cohort Entry Time-Period, Disease Duration & Selected ICD-O-3 Oncologic Phenotypes:
    Milano AF
    J Insur Med; 2019; 48(1):5-23. PubMed ID: 31609640
    [No Abstract]   [Full Text] [Related]  

  • 14. Time trends of incidence of age-associated diseases in the US elderly population: Medicare-based analysis.
    Akushevich I; Kravchenko J; Ukraintseva S; Arbeev K; Yashin AI
    Age Ageing; 2013 Jul; 42(4):494-500. PubMed ID: 23482353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of breast, colorectal, lung, and prostate cancers reported to the National Cancer Data Base and the Surveillance, Epidemiology, and End Results Program.
    Mettlin CJ; Menck HR; Winchester DP; Murphy GP
    Cancer; 1997 May; 79(10):2052-61. PubMed ID: 9149035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time trends in incidence rates and survival of newly diagnosed stage IV breast cancer by tumor histology: a population-based analysis.
    Di Meglio A; Freedman RA; Lin NU; Barry WT; Metzger-Filho O; Keating NL; King TA; Sertoli MR; Boccardo F; Winer EP; Vaz-Luis I
    Breast Cancer Res Treat; 2016 Jun; 157(3):587-96. PubMed ID: 27271765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changing Incidence of Metastatic Prostate Cancer by Race and Age, 1988-2015.
    Dall'Era MA; deVere-White R; Rodriguez D; Cress R
    Eur Urol Focus; 2019 Nov; 5(6):1014-1021. PubMed ID: 29735368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment.
    Edwards BK; Brown ML; Wingo PA; Howe HL; Ward E; Ries LA; Schrag D; Jamison PM; Jemal A; Wu XC; Friedman C; Harlan L; Warren J; Anderson RN; Pickle LW
    J Natl Cancer Inst; 2005 Oct; 97(19):1407-27. PubMed ID: 16204691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increase in the Annual Rate of Newly Diagnosed Metastatic Prostate Cancer: A Contemporary Analysis of the Surveillance, Epidemiology and End Results Database.
    Bandini M; Mazzone E; Preisser F; Nazzani S; Zaffuto E; Marchioni M; Tian Z; Pompe RS; Tilki D; Graefen M; Shariat SF; Montorsi F; Saad F; Briganti A; Karakiewicz P
    Eur Urol Oncol; 2018 Sep; 1(4):314-320. PubMed ID: 31100253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early estimates of SEER cancer incidence, 2014.
    Lewis DR; Chen HS; Cockburn MG; Wu XC; Stroup AM; Midthune DN; Zou Z; Krapcho MF; Miller DG; Feuer EJ
    Cancer; 2017 Jul; 123(13):2524-2534. PubMed ID: 28195651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.